Anti-COVID19 prophylactic paper published in October 2021 already downloaded over 3600 times
Today Nanomerics is pleased to announce that the publication (SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may...
Anti-COVID19 prophylactic paper published in October 2021 already downloaded over 3600 times
Wellcome Board Appointment
Nanomerics announces ocular progress with new patents and two key publications
Nanomerics CSO Prof IF Uchegbu elected to Academy of Medical Sciences
Double Milestone Payment Strengthens Nanomerics' Balance Sheet and Enables Clinical Programs
Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication
Nanomerics receives pIND guidance from the US FDA for NM134